Hepatitis B “Functional Cure” On The Way? A CDMO Helps Out

Great to have an interview with Louis Garguilo, Chief Editor, Outsourced Pharma regarding to one of our lead products, CARG-201 for potential functional cure of patients chronically infected with HBV.

2021 Tech 25: CaroGen targets breakthrough immunotherapy drug

Very honored to be selected by Hartford Business Journal as one of top 25 technology companies in state of Connecticut. We develop breakthrough immunotherapies and vaccines for cancer and infectious diseases.

Bijan Almassian : Striving To Build Super Vaccines and Immunotherapies – Global Business Leaders Mag

Bijan Almassian : Striving To Build Super Vaccines and Immunotherapies While the coronavirus has caused havoc throughout the globe. Another such disease that has haunted humanity for years is cancer. Throughout the years, many cancer researchers have…

CaroGen Corporation: Improving Health around the Globe by Developing Transformative Vaccines and Immunotherapy

It is humbling to be recognized by Healthcare Insight magazine as 10 most advanced biotech startups of 2021.

CaroGen’s Hepatitis B vaccine recommended for $6.8M in federal funding

We are grateful for receiving such a significant grant by Department of Defense to advance our HBV immunotherapy into clinic.

CaroGen Corporation CaroGen Corporation (203) 815-5782